The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.

MBio
Popchai NgamskulrungrojKyung J Kwon-Chung

Abstract

Cryptococcosis is caused by the opportunistic pathogen Cryptococcus neoformans or by the primary pathogen Cryptococcus gattii. Epidemiological studies suggest that patients infected with C. gattii mainly present with pulmonary disease, while those infected with C. neoformans commonly manifest meningoencephalitis. We compared the pathogenesis of the two species using the C. neoformans H99 and C. gattii R265 strains in a murine inhalation model. C. neoformans grew faster in the brain and caused death by meningoencephalitis, while C. gattii grew faster in the lungs and caused death without producing fulminating meningoencephalitis. Despite the consistent failure to recover R265 cells from blood, a fraction of the R265 population was detected in the extrapulmonary organs, including the brain. Upon intravenous (i.v.) inoculation of 10(4) cells via the tail vein, however, C. gattii produced severe meningoencephalitis, demonstrating that C. gattii cells can efficiently cross the blood-brain barrier. Interestingly, i.v. inoculation with five cells caused brain infection in only 10% of C. gattii-infected mice, compared to 60% of mice infected with C. neoformans. In mice that had been initially inoculated via the pulmonary route and subs...Continue Reading

References

Nov 1, 1994·Infection and Immunity·D GoldmanA Casadevall
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S ChenK Byth
Apr 3, 2001·Microbiology·T BoekhoutW Meyer
Feb 27, 2003·Emerging Infectious Diseases·Wieland MeyerUNKNOWN IberoAmerican Cryptococcal Study Group
Jul 15, 2003·Journal of Toxicology and Environmental Health. Part a·G V S RaoAnn F Hubbs
Dec 2, 2004·Proceedings of the National Academy of Sciences of the United States of America·S E KiddW Meyer
Aug 10, 2005·The Journal of Infectious Diseases·Anastasia P LitvintsevaThomas G Mitchell
May 16, 2006·FEMS Yeast Research·Kyung J Kwon-Chung, Ashok Varma
Apr 29, 2008·Emerging Infectious Diseases·Jianghan ChenKyung J Kwon-Chung
Oct 22, 2008·Infection and Immunity·Caroline CharlierFrançoise Dromer
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hansong MaRobin C May
Aug 5, 2009·Infection and Immunity·Popchai NgamskulrungrojJohn R Perfect
Feb 2, 2010·Emerging Infectious Diseases·Eleni GalanisUNKNOWN British Columbia Cryptococcus gattii Working Group
Mar 25, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P NgamskulrungrojW Meyer
Apr 13, 2010·Eukaryotic Cell·Kerstin Voelz, Robin C May
Apr 29, 2010·The Journal of Clinical Investigation·Arturo Casadevall
Apr 29, 2010·The Journal of Clinical Investigation·Meiqing ShiChristopher H Mody
Jun 17, 2010·Mycopathologia·Mark B KrockenbergerWieland Meyer
Jun 30, 2010·PLoS Pathogens·Oscar ZaragozaArturo Casadevall
Jun 30, 2010·PLoS Pathogens·Laura H OkagakiKirsten Nielsen

❮ Previous
Next ❯

Citations

May 15, 2013·Infection and Immunity·Pinkuan ZhuAlexander Idnurm
Oct 19, 2012·Future Microbiology·Wilber Sabiiti, Robin C May
Sep 24, 2013·Mediators of Inflammation·Yoichiro OkuboKazutoshi Shibuya
Apr 9, 2014·Journal of Immunological Methods·Tobias M Hohl
Jan 1, 2012·Medical Mycology Case Reports·Aurora Villarroel, Tessa R Maggiulli
Jan 1, 2015·Journal of Fungi·Kyung J Kwon-Chung, Tomomi Saijo
Mar 5, 2016·Medical Mycology Journal·Akiko Miyazato
Nov 29, 2015·FEMS Yeast Research·Ewa Bielska, Robin C May
Oct 20, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yurika Ikeda-DantsujiYoshitsugu Miyazaki
Jul 15, 2015·Scientific Reports·Jéssica RodriguesMarcio L Rodrigues
Dec 17, 2014·Fungal Genetics and Biology : FG & B·Josie F Gibson, Simon A Johnston
Oct 15, 2014·Fungal Genetics and Biology : FG & B·John R Perfect, Tihana Bicanic
Feb 28, 2015·Fungal Genetics and Biology : FG & B·Ferry HagenTeun Boekhout
Feb 27, 2015·Cellular and Molecular Life Sciences : CMLS·Muthulekha SwamydasMichail S Lionakis
Oct 4, 2014·Clinical Microbiology Reviews·Sharon C-A ChenTania C Sorrell
Aug 8, 2015·PLoS Pathogens·Edward SionovKyung J Kwon-Chung
Oct 19, 2016·Survey of Ophthalmology·Mohammed RigiAndrew G Lee
Aug 8, 2015·Anais Da Academia Brasileira De Ciências·Ana Caroline Colombo, Marcio L Rodrigues
Jan 16, 2018·Journal of Fungi·Liliane Mukaremera, Kirsten Nielsen
May 2, 2018·Infection and Immunity·Joudeh B FreijArturo Casadevall
Nov 11, 2017·Virulence·Michael J Davis, Michail S Lionakis
May 19, 2019·Disease Models & Mechanisms·Liesbeth VanherpGreetje Vande Velde
Sep 19, 2014·Medical Mycology Journal·Ichiro KawamuraHanako Kurai
Aug 27, 2019·Innate Immunity·Patrícia Kellen Martins Oliveira-BritoThiago Aparecido da Silva
Apr 29, 2020·Medical Mycology·Anderson Mançan Vilas-BôasMario Léon Silva-Vergara

❮ Previous
Next ❯

Software Mentioned

SPSS statistics

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.